Latest Blogs

Feb 14, 2019
It's hard enough to try dating again after a cancer diagnosis and treatment, but some of my patients also face strong opposition from their adult children.
Feb 14, 2019
Dr. Suneel D. Kamath was surprised to learn how important laughter and levity can be in the physician-patient relationship.
Feb 11, 2019
When a patient asks, "Why me?", Dr. Stephanie Graff considers that they may not be asking for a list of their cancer risk factors.
Feb 07, 2019
Dr. Gottlieb discusses the FDA's efforts to increase overall efficiency by updating or modernizing aspects of our clinical trials conduct and expediting the end-to-end drug development process, as well as controlling the next generation of tobacco products.
Subscribe to this column

George W. Sledge, MD, FASCO

George W. Sledge, Jr., MD, FASCO, is Chief of the Division of Oncology and Professor of Medicine at Stanford University School of Medicine. Prior to joining Stanford, he was Co-Director of the Breast Cancer Program as well as the Ballve-Lantero Professor of Oncology and Professor of Medicine and Pathology at the Indiana University Simon Cancer Center. He was the 2010-2011 President of ASCO, and he has served on numerous ASCO committees. He has also served as Chair of the Breast Committee of the Eastern Cooperative Oncology Group from 2002-2009. Dr. Sledge is currently a member of the Measures Task Force, as well as the Quality of Care and CancerLinQ Patient Reported Outcomes Committees. He received the 2006 Komen Foundation Brinker Award for Scientific Distinction in 2006, The Breast Cancer Research Foundation Jill Rose Award, and the William L. McGuire Award from the San Antonio Breast Cancer Symposium in 2010.

Mar 22, 2011
As an organization of clinical oncologists, ASCO has a special and lasting interest in the fate of the nation's ...
Mar 16, 2011
A few months ago I told you about the Education Committee and its important role in developing an educational program for our...
Mar 14, 2011
Discussions of cancer care begin with science and end with economics and politics. This is true within countries, but is particularly the case when we cross borders. While there is much about cancer that is common everywhere — smoking-induced lung cancer has pretty much the same biology in Beijing...
Mar 05, 2011
There is an interesting article by Dr. Pauline Chen in the March 3rd New York Times on the ethics of early phase clinical trials. The article discusses in particular the issue of optimism.
Feb 28, 2011
You could, I think, write the history of our specialty by looking at the history of our Annual Meeting. Certainly some of the great moments that I recall from past meetings—in the past decade think of imatinib for GIST tumors, adjuvant trastuzumab for breast cancer, and last year’s crizotinib trial...
Feb 17, 2011
Does anyone other than me find what happened on Jeopardy! this week somewhat freaky? For those of you not up with the cultural zeitgeist, an IBM computer named Watson absolutely destroyed the two best Jeopardy! contestants in a three-day contest, answering question after question correctly in an...

Pages